National Adult Vaccination Program

GSA is dedicated to bringing the diverse interdisciplinary team together to increase reverence for vaccines.

In 2010, GSA established the National Adult Vaccination Program to improve adult immunization rates. During the past decade, GSA has convened and collaborated with the multidisciplinary stakeholder community to raise awareness of the natural immunosenescence that occurs as we age; advocating for policies that are favorable to the access of vaccines; and training champions to stimulate vaccination policies and rates.

In 2022, our objective is to Catalyze The Diverse Multidisciplinary Team To Champion Vaccination.

NAVP will:

• Convene multidisciplinary experts annually to address current vaccine issues for older adults and
  identify sustainable solutions
• Disseminate current insights and implications from therapeutic advances and enhanced delivery
  of vaccines
• Advocate for policies that improve adult vaccination rates

The GSA NAVP is guided by a group of vaccine and policy experts that provide strategic recommendations and direction:

	R. Gordon Douglas, MD (Chair) Professor Emeritus of Medicine Weill Cornell Medical College		Stefan Gravenstein, MD, FGSA David S. Greer Professor of Geriatric Medicine Director, Division of Geriatrics and Palliative Care Brown University Schools of Medicine and Public Health
	Michelle Cantu, MPH Senior Director, Immunization & MCAH National Association of County and City Health Officials		Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, FGSA Sonya Ziporkin Gershowitz Chair in Gerontology University of Maryland
	Danielle Casanova, MBA Senior Director, Population Health Initiatives American Medical Group Foundation		William Schaffner, MD Professor of Preventive Medicine in the Department of Health Policy Professor of Medicine in the Division of Infectious Diseases Vanderbilt University School of Medicine

NAVP is developed by The Gerontological Society of America and supported by: